tiprankstipranks
Trending News
More News >
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market

Oryzon Genomics SA (ORN) Income Statement

Compare
1 Followers

Oryzon Genomics SA Income Statement

Last quarter (Q2 2025), Oryzon Genomics SA's total revenue was €4.22M, an increase of Infinity% from the same quarter last year. In Q2, Oryzon Genomics SA's net income was €103.34K. See Oryzon Genomics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 7.36M€ 0.00€ 0.00€ 10.62M€ 9.52M
Gross Profit
€ 7.06M€ 13.95M€ 15.23M€ 9.87M€ 8.99M
Operating Expenses
€ 11.48M€ 18.50M€ 20.72M€ 16.88M€ 13.28M
Depreciation and Amortization
€ 147.75K€ 130.13K€ 146.59K€ 144.33K€ 132.62K
EBITDA
€ -4.43M€ -4.43M€ -5.35M€ -6.88M€ -4.16M
Operating Income
€ -4.42M€ -4.55M€ -5.49M€ -7.01M€ -4.29M
Other Income/Expenses
€ -1.15M€ -1.55M€ -1.07M€ -169.00K€ -485.00K
Pretax Income
€ -5.57M€ -6.10M€ -6.56M€ -7.18M€ -4.78M
Net Income
€ -3.67M€ -3.35M€ -4.23M€ -4.69M€ -3.40M
Per Share Metrics
Basic EPS
€ -0.06€ -0.06€ -0.08€ -0.09€ -0.06
Diluted EPS
€ -0.06€ -0.06€ -0.08€ -0.09€ -0.06
Weighted Average Shares Outstanding
64.37M 60.88M 56.04M 52.76M 52.76M
Weighted Average Shares Outstanding (Diluted)
64.37M 60.88M 56.04M 52.76M 52.76M
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History